{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:18:43Z","timestamp":1791119923178,"version":"4.1.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Statin-associated immune-mediated necrotizing myopathy (IMNM) is an idiopathic inflammatory myopathy (IIM) associated with anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (anti-HMGCR) antibodies. This research determined the characteristics and outcomes of Native Americans vs non-Native Americans (non-NA) diagnosed with IIM and IMNM from the American Southwest.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective single-institution study, IIM diagnosis was established with standard criteria, and statin-associated IMNM diagnosis required the presence of anti-HMGCR antibodies. Of 148 subjects with IIM, 33 self-identified as Native American and 115 as non-NA. The proportion of IIM and IMNM in each group, clinical and laboratory parameters, and the outcomes were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with non-NA, Native Americans with IIM had a lower body mass index, myositis damage index and inflammatory arthritis, but more hyperlipidemia (75% vs 49.6%; P\u2009=\u20090.015), statin exposure (71.9% vs 40.0%; P\u2009=\u20090.002), diabetes mellitus (DM) (62.5% vs 34.8%; P\u2009=\u20090.044) and esophageal dysmotility (93.8% vs 77.4%; P\u2009=\u20090.042). Native Americans more frequently expressed anti-RNP antibody (15.6% vs 2.6%, P\u2009=\u20090.013) and anti-HMGCR antibody (46.9% vs 16.5%, P\u2009=\u20090.0007). The estimated prevalence of statin-associated IMNM in Native Americans vs non-NA was 182 vs 30.6 cases\/106 population, and incidence was 66.4 vs 7.5 cases\/year\/106 population. There were no significant differences in the clinical outcomes and treatment received between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Statin-associated IMNM is significantly more common in Native Americans in the American Southwest. The treatments received and outcomes of statin-associated IMNM in Native Americans and non-NA seem to be similar. The underlying genetic and environmental factors predisposing to IMNM in these populations require further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf618","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:31:50Z","timestamp":1763645510000},"source":"Crossref","is-referenced-by-count":2,"title":["Increased prevalence and incidence of statin-associated immune-mediated necrotizing myopathy in Native Americans"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2351-8551","authenticated-orcid":false,"given":"Tam N","family":"Dinh","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-7518","authenticated-orcid":false,"given":"Evelyn E","family":"Inga","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M","family":"Waters","sequence":"additional","affiliation":[{"name":"University of New Mexico Medical Group, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janell","family":"Francisco","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of New Mexico Hospital , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4887-3092","authenticated-orcid":false,"given":"Krystle L","family":"Tapia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of New Mexico Hospital , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-1031","authenticated-orcid":false,"given":"Maheswari","family":"Muruganandam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2241-5464","authenticated-orcid":false,"given":"N Suzanne","family":"Emil","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3579-8073","authenticated-orcid":false,"given":"Frank X","family":"O\u2019Sullivan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-160X","authenticated-orcid":false,"suffix":"Jr","given":"Wilmer L","family":"Sibbitt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of New Mexico Health Sciences Center , Albuquerque, NM,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"2026022606030691900_keaf618-B1","doi-asserted-by":"publisher","first-page":"e0226516","DOI":"10.1371\/journal.pone.0226516","article-title":"Population-based estimates of humoral autoimmunity from the U.S. National Health and Nutrition Examination Surveys, 1960\u20132014","volume":"15","author":"Dillon","year":"2020","journal-title":"PLOS ONE"},{"key":"2026022606030691900_keaf618-B2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1002\/art.42330","article-title":"Increasing prevalence of antinuclear antibodies in the United States","volume":"74","author":"Dinse","year":"2022","journal-title":"Arthritis Rheum"},{"key":"2026022606030691900_keaf618-B3","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.rdc.2020.07.006","article-title":"Understanding the disproportionate burden of rheumatic diseases in indigenous North American populations","volume":"46","author":"Ferucci","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"key":"2026022606030691900_keaf618-B4","article-title":"Idiopathic inflammatory myopathies in Alaska Native\/American Indian people in Alaska [abstract]","volume":"74","author":"Mehta","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026022606030691900_keaf618-B5","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: a history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2026022606030691900_keaf618-B6","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026022606030691900_keaf618-B7","author":"New Mexico True","year":"2025"},{"key":"2026022606030691900_keaf618-B8","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/art.42126","article-title":"Increased risk of statin-associated autoimmune myopathy among American Indians","volume":"74","author":"Wei","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026022606030691900_keaf618-B9","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/rheumatology\/keaa337","article-title":"Potential implications of six American Indian patients with myopathy, statin exposure and anti-HMGCR antibodies","volume":"60","author":"Close","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030691900_keaf618-B10","doi-asserted-by":"publisher","first-page":"4855","DOI":"10.1093\/rheumatology\/keac198","article-title":"Statin-associated immune-mediated necrotizing myositis in Native Americans","volume":"61","author":"Muruganandam","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030691900_keaf618-B11","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026022606030691900_keaf618-B12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.17219\/acem\/141181","article-title":"Characteristics of idiopathic inflammatory myopathies with novel myositis-specific autoantibodies","volume":"30","author":"Rams","year":"2021","journal-title":"Adv Clin Exp Med"},{"key":"2026022606030691900_keaf618-B13","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1002\/art.24904","article-title":"Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index","volume":"60","author":"Rider","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026022606030691900_keaf618-B14","first-page":"458","article-title":"Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization","volume":"35","author":"Hsu","year":"2008","journal-title":"J Rheumatol"},{"key":"2026022606030691900_keaf618-B15","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026022606030691900_keaf618-B16","author":"Moss-Adams","year":"2016"},{"key":"2026022606030691900_keaf618-B17","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen","year":"2016","journal-title":"N Engl J Med"},{"key":"2026022606030691900_keaf618-B18","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1001\/archinte.165.22.2671","article-title":"Outcomes in 45 patients with statin-associated myopathy","volume":"165","author":"Hansen","year":"2005","journal-title":"Arch Intern Med"},{"key":"2026022606030691900_keaf618-B19","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/TCRM.S197941","article-title":"Statin-Associated Autoimmune Myopathy: current perspectives","volume":"16","author":"Tiniakou","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"2026022606030691900_keaf618-B20","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.nmd.2017.09.016","article-title":"224th ENMC International Workshop: clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14-16 October 2016","volume":"28","author":"Allenbach","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"2026022606030691900_keaf618-B21","doi-asserted-by":"publisher","first-page":"e13625","DOI":"10.1111\/obr.13625","article-title":"Physiologic hormone administration improves HbA1C in Native Americans with type 2 diabetes: a retrospective study and review of insulin secretion and action","volume":"24","author":"Rebello","year":"2023","journal-title":"Obes Rev"},{"key":"2026022606030691900_keaf618-B22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s00125-020-05348-5","article-title":"Lower insulin clearance is associated with increased risk of type 2 diabetes in Native Americans","volume":"64","author":"Shah","year":"2021","journal-title":"Diabetologia"},{"key":"2026022606030691900_keaf618-B23","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1093\/hmg\/ddq173","article-title":"A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans","volume":"19","author":"Acu\u00f1a-Alonzo","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2026022606030691900_keaf618-B24","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1756-185X.2010.01470.x","article-title":"Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus","volume":"13","author":"Limaye","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"2026022606030691900_keaf618-B25","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB111:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026022606030691900_keaf618-B26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.atherosclerosis.2015.03.025","article-title":"Genetic and immunologic susceptibility to statin-related myopathy","volume":"240","author":"Patel","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026022606030691900_keaf618-B27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti HMGCR autoantibodies","volume":"48","author":"Mohassel","year":"2013","journal-title":"Muscle Nerve"},{"key":"2026022606030691900_keaf618-B28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/j.1399-0039.2005.00495.x","article-title":"HLA-A and HLA-B allele frequencies in a mestizo population from Guadalajara, Mexico, determined by sequence-based typing","volume":"66","author":"Leal","year":"2005","journal-title":"Tissue Antigens"},{"key":"2026022606030691900_keaf618-B29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.therap.2023.07.005","article-title":"Statins and immune-mediated necrotizing myopathy: variability in the risk","volume":"79","author":"Trenque","year":"2024","journal-title":"Therapie"},{"key":"2026022606030691900_keaf618-B30","author":"American Diabetes Association","year":"2025"},{"key":"2026022606030691900_keaf618-B31","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2337\/diacare.16.1.306","article-title":"Diabetes mortality among New Mexico\u2019s American Indian, Hispanic, and non-Hispanic white populations, 1958-1987","volume":"16","author":"Carter","year":"1993","journal-title":"Diabetes Care"},{"key":"2026022606030691900_keaf618-B32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/oxfordjournals.aje.a115083","article-title":"Diabetes, gallbladder disease, obesity, and hypertension among Hispanics in New Mexico","volume":"128","author":"Samet","year":"1988","journal-title":"Am J Epidemiol"},{"key":"2026022606030691900_keaf618-B33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00296-022-05161-w","article-title":"The diagnostic challenge of patients with anti-U1-RNP antibodies","volume":"43","author":"Elhani","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026022606030691900_keaf618-B34","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.2147\/IJGM.S464704","article-title":"Interstitial lung disease in patients with mixed connective tissue disease: a Retrospective Study","volume":"17","author":"Shan","year":"2024","journal-title":"Int J Gen Med"},{"key":"2026022606030691900_keaf618-B35","doi-asserted-by":"publisher","first-page":"e000247","DOI":"10.1136\/lupus-2017-000247","article-title":"Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus","volume":"5","author":"Kheir","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2026022606030691900_keaf618-B36","doi-asserted-by":"publisher","first-page":"2166447","DOI":"10.1080\/22423982.2023.2166447","article-title":"Disparities in rheumatoid arthritis outcomes for North American Indigenous populations","volume":"82","author":"Hitchon","year":"2023","journal-title":"Int J Circumpolar Health"},{"key":"2026022606030691900_keaf618-B37","doi-asserted-by":"publisher","first-page":"luae227","DOI":"10.1210\/jcemcr\/luae227","article-title":"Statin-induced necrotizing autoimmune myopathy: diagnosis and treatment approach","volume":"2","author":"Srinivasan","year":"2024","journal-title":"JCEM Case Rep"},{"key":"2026022606030691900_keaf618-B38","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1002\/acr.25406","article-title":"Benefits of early versus late initiation of intravenous immunoglobulin in the treatment of patients with Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme a reductase immune-mediated necrotizing myopathy","volume":"76","author":"Sharf","year":"2024","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026022606030691900_keaf618-B39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/jgh3.12946","article-title":"Autoimmune hepatitis and overlap syndrome among Alaska Native people: prevalence, clinical characteristics, and remission","volume":"7","author":"Johnston","year":"2023","journal-title":"JGH Open"},{"key":"2026022606030691900_keaf618-B40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/acr.24795","article-title":"Unique serum immune phenotypes and stratification of Oklahoma Native American rheumatic disease patients","volume":"75","author":"Slight-Webb","year":"2923","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf618\/65465117\/keaf618.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf618\/65465117\/keaf618.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf618\/65465117\/keaf618.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:03:13Z","timestamp":1772103793000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf618\/8340047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf618","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,21]]},"article-number":"keaf618"}}